We are developing first-in-class protein degradation therapeutics to degrade & destroy disease-causing proteins via the body's own protein disposal system.
http://www.arvinas.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
0.2 seconds
16x16
32x32
Arvinas Inc.
Matthew Civale
5 Sci●●●●● Park
New●●●ven , Connecticut, 06511
United States
View this contact
Arvinas Inc.
Matthew Civale
5 Sci●●●●● Park
New●●●ven , Connecticut, 06511
United States
View this contact
Arvinas Inc.
Matthew Civale
5 Sci●●●●● Park
New●●●ven , Connecticut, 06511
United States
View this contact
BUY YOUR DOMAIN
11
YEARS
8
MONTHS
3
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
14
SSL
EXTERNAL LINKS
6
SITE IP
23.235.208.55
LOAD TIME
0.156 sec
SCORE
6.2
Arvinas: A Revolutionary Approach to Treating Cancers, Other Diseases | arvinas.com Reviews
https://arvinas.com
We are developing first-in-class protein degradation therapeutics to degrade & destroy disease-causing proteins via the body's own protein disposal system.
arvinas.com
Latest News | Arvinas
http://arvinas.com/news
Skip to main content. Arvinas Publishes First Peer-Reviewed, In Vivo Data from its Proprietary PROTAC Technology. Arvinas to Present Data at the 2016 AACR Annual Meeting. Arvinas Appoints Angela Shen as Chief Medical Officer. Arvinas Presents Data at the 2015 ASH Annual Meeting. Arvinas Secures $41.6M Series B Financing Appoints New Board Members. Arvinas Inks Strategic License Agreement with Genentech. FierceBiotech names Arvinas as one of its Fierce 15 Biotech Companies of 2015.
Protein Degradation Platform | Arvinas
http://arvinas.com/protein-degradation-platform
Skip to main content. Arvinas has developed a platform technology to induce the loss of intracellular proteins:. The ability of PROTAC-based drugs to induce protein degradation (instead of protein inhibition) offers the advantage of potentially targeting undruggable as well as druggable elements of the proteome. This greatly expands our ability to create drugs for many new, previously unapproachable targets.
Proteolysis-Targeting Chimera (PROTAC) | Arvinas
http://arvinas.com/protein-degradation-platform/proteolysis-targeting-chimera-protac
Skip to main content. Our protein degradation platform uses bifunctional small molecules, Proteolysis-Targeting Chimeras (PROTACs), to target proteins for removal from the cell. PROTACs recruit an E3 ubiquitin ligase to a specific targeted protein, thereby labeling that protein for elimination by the Ubiquitin/Proteasome System (UPS). BRD4 Degrader produces long lasting loss of BRD4 protein and robust efficacy in Burkitt’s Lymphoma, Multiple Myeloma and Prostate Cancer cells.
Publications | Arvinas
http://arvinas.com/publications
Skip to main content. PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Kanak Raina, PhD., et al. BRD4 Degradation by PROTACs Represents a More Effective Therapeutic Strategy than BRD4 Inhibitors in Ovarian Cancer. Kanak Raina, PhD., et al. Hijacking Ubiquitin E3 Ligases Using PROTAC Technology to Effectively Degrade BRD4 and Achieve Anti-tumor Efficacy. ACS Meeting March 2016. Yimin Qian, PhD., et al. Jim Winkler, PhD. Jing Lu, PhD., et al. Patients with prost...
Scientific Advisory Board | Arvinas
http://arvinas.com/about/scientific-advisory-board
Skip to main content. Craig M. Crews, Ph.D. Is the Founder and Chief Scientific Advisor of Arvinas as well as the L.B. Cullman Professor of Molecular, Cellular and Developmental Biology, Chemistry and Pharmacology at Yale University. And became carfilzomib/Kyprolis , which received FDA approval for relapsed/refractory multiple myeloma in 2012. Daniel D. Von Hoff, M.D., F.A.C.P. Dr Von Hoff is the past President of the American Association for Cancer Research (the world’s largest cancer research organizat...
TOTAL PAGES IN THIS WEBSITE
14
New Haven Startup Tour
http://www.educatedsolutionsllc.com/nhstartup
The New Haven Startup Tour. Friday, Nov 14 12:00pm - 5:30pm. The New Haven Startup Tour. Provides the opportunity to look behind the scenes of New Haven area startups. You will get a chance to visit each company (usually in their offices) and meet the founders, talk to employees, and discover a whole world of opportunity most never knew existed in the New Haven area. Best of all it's FREE!
New Leaf Venture Partners - Portfolio
http://www.nlvpartners.com/portfolio.html
With the success of our entrepreneurs our portfolio has. 20 billion-dollar companies, 34 acquired companies,. And 39 companies taken public, with more to come. Artificial intelligence platform that confirms medication adherence in clinical trials and high-risk patient populations. New York, NY. Platform for small-molecule drugs that induce targeted degradation of disease-causing intracellular proteins. New Haven, CT. NLV III / GROWTH. NLV III / GROWTH. NLV III / GROWTH. Berkeley Heights, NJ. New York, NY.
New Ventures | Office of Cooperative Research
http://ocr.yale.edu/new-ventures
Skip to main content. Office of Cooperative Research. Yale Device and Diagnostic Pipeline. Browse Faculty Research Interests. Patent Policy Acknowledgement and Agreement. Inventors' Distribution Agreement. Management of Equity in New Ventures. Committee on Cooperative Research. Consulting and the Patent Policy. Browse Faculty Research Interests. Patent Policy for Students. Support for Yale Student Innovators. Advanced Orthopedic Technologies is commercializing an innovative approach to repairing cartilag...
5AM Ventures | Portfolio
http://5amventures.com/portfolio
THE 5AM PORTFOLIO: COMPANY PROFILES. Achaogen (AKAO) is a biopharmaceutical company developing small molecule therapeutics to treat infections caused by multi-drug resistant bacterial. IPO in March 2014. Alexza (ALXA) is a biopharmaceutical company developing drugs for local and systemic delivery through the lung. IPO in March 2006. Aprea is a biopharmaceutical company developing small molecule therapeutics for the treatment of cancer by reactivating mutant p53 tumor suppressor function. Calibrium is a b...
TOTAL LINKS TO THIS WEBSITE
6
:::: -This Site is Under Construction- ::::
This page uses frames, please update your browser.
ArvinArt (Arvin) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) " class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 5 Years. This deviant's full pageview. Last Visit: 194 weeks ago. This is the place where you can personalize your profile! By moving, adding and personalizing widgets. Why," you ask? Jul 14, 2010.
Arvin Aryafar | Toronto Real Estate Broker
I want to buy. I want to sell. I want to buy. I want to sell. Elcome to my Website! Name is Arvin Aryafar. I am a registered Real Estate Broker with Toronto Real Estate Board (TREB). Working with Century 21. Your Number One Realty Inc Brokerage, I am a member of Canadian Real Estate Assosiation (CREA), Real Estate Counsil of Ontario (RECO) and Ontario Real Estate Assosiation (OREA). Academic background in economics and finance coupled with my extensive experience in corporate management in sales and mark...
حرف هایی که باید زد
حرف هایی که باید زد. دلنوشته های یک پسر خجالتی. اینم اخرین اپم واسه وبلاگ و اخرین حرفام! تو این مدت که وبلاگم باز بود دوستای خوبی پیدا کردم و کلی چیز میز یاد گرفتم . همتون رو دوست دارم و خواهم داشت . اگر خواستید باهام در تماس باشید میتونید همینجا کامنت بذارید . بازم میگم همتون رو دوست دارم . اینم ایمیل و شماره من هست ولی خواهشا زنگ نزنید اگر امری فرمایشی چیزی داشتید فقط پیامک بدید. کسی خواست لینک بذاره لینکش کنم. دوستون دارم دوستون دارم دوستون دارم. نوشته شده در ساعت 16:38 توسط آروین. لطفا برای دیدن ادام...
Arvinas: A Revolutionary Approach to Treating Cancers, Other Diseases
News & Publications. Arvinas Presents New Preclinical Data on Oral Androgen Receptor PROTAC ARV-110 at ASCO 2018 Genitourinary Cancers Symposium. Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug Candidates. Arvinas Nominates Oral Clinical Candidate for Estrogen Receptor Degrader Program. Arvinas Presents New Preclinical Data on Oral Androgen Receptor PROTAC ARV-110 at ASCO 2018 Genitourinary Cancers Symposium.
mysite
Create a free website. Start your own free website. A surprisingly easy drag and drop site creator. Learn more.
آروین عسلی
سخت ترین کار دنیا. خوابوندن همزمان آروین و سامین. نوشته شده در سه شنبه هفدهم دی 1392ساعت 11:38 توسط مامان آروین. نوشته شده در شنبه هجدهم آبان 1392ساعت 17:18 توسط مامان آروین. فقط ده روز دیگر فرصت باقیست! نوشته شده در پنجشنبه نهم آبان 1392ساعت 12:8 توسط مامان آروین. خیلی وقته ننوشتم اما الان دلم میخواد بنویسم آخه یه حس خوبی دارم. بازم مثل یه معجزه. مثل از شیر گرفتنش با اون همه وابستگی. مثل از پوشک گرفتنش به اون راحتی. آروین سه ساله من عاشقتم و بیقراررررررررررررررر. بمان برای من بمان دو چشمت آسمان من.
ArvinaSalon.com | Sanggar Rias Pengantin Murah
ArvinaSalon.com Sanggar Rias Pengantin Murah. ArviaSalon.com merupakan sanggar rias pengantin dengan harga murah yang berlokasi di darah Tangerang. Paket Acara Di Rumah. Paket A (500 Orang). Paket B (800 Orang). Paket C (1000 Orang). Selamat datang di ArvinaSalon.com Wedding Organizer dan Rias Pengantin dengan layanan prima untuk keperluan pesta pernikahan anda. Daftar harga paket pernikahan di gedung/aula di arvina.com. Daftar harga paket pernikahan di Rumah di arvina.com. This is featured post 4 title.
خواندنیها
کارشناس ارشد MBA و مشاور سازمانی. انتخاب منظر مناسب برای گفتگو. رهبر استراتژیک واقعی مهارت مدیریت هم زمان چندین ابتکار(initiative) را دارند. به عنوان مثال. شرایط داخلی (کارکنان ، فرایندها، فرهنگ و غیره ) را در نظر می گیرد و همچنین شرایط خارجی مانند روندهای بازار ، نیازهای مشتری ، دورنمای رقابتی و غیره را ارزیابی می کند و اقدامات مهمی را طراحی و اجرا می کند. این اقدمات را انجام می دهد تا به اهداف کوتاه مدت و بلند مدت دست یابد. برای هر دوی این موارد اوج گرفتن. نقش مدیران جلسه در ایجاد. فرق دقت با وسواس.
Arvin's Portfolio | Robots!
Department of Electrical and Computer Engineering. 4400 University Drive,. Fairfax, VA 22030, USA. I would like to welcome you to my website, where you can get to know about my endeavors in the cool field of robotics! I am a graduate student from George Mason University pursuing my masters in Electrical Engineering, specializing in Controls and Robotics. Robotics has been a fascination of mine right from my childhood and robots play a very important part in various fields of science and engineering.
SOCIAL ENGAGEMENT